本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

德納維製藥

10.58
-0.3200-2.94%
盤後10.580.00000.00%19:36 EDT
成交量:384.09萬
成交額:4,068.60萬
市值:12.70億
市盈率:-22.56
高:10.88
開:10.72
低:10.56
收:10.90
資料載入中...
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

重要事件披露

Form 8-K - Current report
2023/11/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/14

重要事件披露

Form 8-K - Current report
2023/09/02

重要事件披露

Form 8-K - Current report
2023/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities